Pharmaceuticals Trio Draw Buy Ratings Ahead of 2026 Catalysts
A trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Understanding when index funds are worth it depends on time horizon and fees. This quick guide outlines key scenarios and considerations.
14,180 articlesA trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Two decades after the Iraq War, Iran's footprint in Iraqi politics and security is shaping energy markets and investo...
Private equity stocks have fallen about 30%-40% over the last three months, driven by macro pressures and liquidity c...
New Jersey's budget proposal would trim senior property tax relief by tightening Stay NJ and related programs, as law...
Breaking news: the U.S. says it has hit military targets on Kharg Island in Iran, escalating a regional clash. Market...
USDC has overtaken USDT in transfer volume for the first time since 2019, highlighting a shift in how crypto traders ...
Bitcoin climbs back above key levels as ETF inflows resume and institutions accumulate, fueling a broad crypto-market...
The Federal Reserve left its policy rate unchanged at its March 2026 meeting as inflation cools but the jobs market r...
Even with about $1.1 billion flowing into Bitcoin ETFs, prices keep slipping. This article explains why inflows don’t...
A headline-grabbing $60 million deal with Harry and Meghan raised questions about value, expectations, and how to mea...
A prompt-driven AI nicknamed Grok projects sharp gains for XRP, Bitcoin, and Ethereum by late 2026, even as oil-drive...
GLAD faces a delicate turning point as the Fed freezes rates, pressuring yields on its floating-rate loans while port...